Podcast Episodes
Back to Search
M&A Ticks Up, ASCO Excites and Vaccines Cause More Drama
The words of the week so far in biopharma are “deals” and “cancer”—or, more specifically, money being invested in cancer and other key therapeutic ar…
1 year, 1 month ago
COVID-19 Vaccine Overhaul, Rocket Grounded, ‘One Tough Hombre’ on MFN
The name of the biopharma game this season is vaccines—and RFK Jr. wasted no time returning from Memorial Day Weekend before making news on this fron…
1 year, 1 month ago
How Target Product Profiles Guide the Industry Through Uncertain Times
Lori Ellis, head of insights and Ian Fisher, head of development of analytics at IQVIA, discusses the critical importance of Target Product Profiles …
1 year, 1 month ago
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
Pfizer stole the headlines this week with a pact worth up to $6 billion with Chinese biotech 3SBio for a PD-1/VEGF candidate just three months after …
1 year, 1 month ago
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
President Donald Trump unveiled a sweeping drug pricing policy this week, seeking to lower drug prices in the U.S. by up to 80% through a reprisal of…
1 year, 1 month ago
Eroding Immunity: Vaccine Hesitancy and Cynicism
Paul Offit, MD, Director of the Vaccine Education Center at the Children's Hospital of Philadelphia and the Maurice R. Hilleman Professor of Vaccinol…
1 year, 2 months ago
Trump’s US Manufacturing Push, New Vaccine Policy, Novo’s Weight Loss Pill up for FDA Review
In his effort to onshore manufacturing, President Donald Trump issued an executive order on Monday afternoon ordering the FDA to ease permitting proc…
1 year, 2 months ago
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
Policy issues—particularly tariffs—loom large as Q1 2025 earnings season rolls on, with Pfizer , Novartis, AstraZeneca and many more all reporting th…
1 year, 2 months ago
Economic Challenges, Strategic Investments: Reshaping the Women's Health Landscape
This discussion features BioSpace's head of insights Lori Ellis, Kearney partner Martin Hadosi, and Melissa Laitner, director of strategic initiative…
1 year, 2 months ago
Makary’s First Interview, US Manufacturing Push and Lilly vs. Novo in Obesity Pill Race
While much of the country was off celebrating Easter and Passover this weekend, the FDA—and its new leader Marty Makary—were busy making news. Makary…
1 year, 2 months ago